BARCA, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 1.030
EU - Europa 845
AS - Asia 362
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.238
Nazione #
US - Stati Uniti d'America 1.027
IE - Irlanda 319
SE - Svezia 271
CN - Cina 232
SG - Singapore 99
IT - Italia 65
PL - Polonia 52
FI - Finlandia 50
DE - Germania 27
GB - Regno Unito 21
IN - India 18
BE - Belgio 17
NL - Olanda 7
UA - Ucraina 6
IR - Iran 5
FR - Francia 4
VN - Vietnam 4
CA - Canada 3
ID - Indonesia 2
RU - Federazione Russa 2
AT - Austria 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
EU - Europa 1
JP - Giappone 1
KR - Corea 1
NO - Norvegia 1
Totale 2.238
Città #
Dublin 318
Chandler 210
Nyköping 150
Singapore 75
Beijing 74
Dearborn 66
Ann Arbor 61
Jacksonville 59
Princeton 54
Warsaw 52
Cambridge 51
Medford 50
Ashburn 47
Des Moines 40
New York 25
Jinan 23
San Mateo 23
Messina 22
Wilmington 21
Shenyang 19
Boardman 18
Lancaster 16
Brussels 15
Ningbo 14
Nanjing 12
Hangzhou 11
Los Angeles 11
Hebei 10
Houston 10
Hyderabad 10
Bremen 9
Taizhou 8
Changsha 7
Haikou 7
Tianjin 7
Cagliari 6
Helsinki 6
Rome 6
Zhengzhou 6
Norwalk 5
Catania 4
Dong Ket 4
Fairfield 4
Pune 4
Washington 4
Ardabil 3
Falls Church 3
Fuzhou 3
Guangzhou 3
Mineo 3
Nanchang 3
Santa Clara 3
Strasbourg 3
Torino 3
Hefei 2
Jakarta 2
Jiaxing 2
Las Vegas 2
Leawood 2
Milan 2
Monmouth Junction 2
Montreal 2
Munich 2
Seattle 2
Taiyuan 2
Waanrode 2
Augusta 1
Avigliano 1
Chaoyang 1
Clifton 1
Frankfurt am Main 1
Gorey 1
Grafton 1
Kunming 1
Lanzhou 1
Milazzo 1
Mumbai 1
Nanyang 1
Naples 1
Nürnberg 1
Olomouc 1
Oslo 1
Sabz 1
Tappahannock 1
Tokyo 1
Tomsk 1
Toronto 1
Vienna 1
Whiteville 1
Woodbridge 1
Wuhan 1
Totale 1.730
Nome #
Intracranial arterial abnormalities in patients with late onset Pompe disease (LOPD) 86
Impaired Muscle Mitochondrial Biogenesis and Myogenesis in Spinal Muscular Atrophy 76
Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study 75
The Role of Mitochondria in Cerebellar Ataxias 75
Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment 69
Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias 69
Auditory system involvement study in 20 patients with late-onset Pompe disease 64
Ruolo patogenetico dei microRNAs nelle calpainopatie 59
Are there ERT defined guidelines for Pompe disease? 58
A study of auditory system in 20 patients with late onset Pompe disease 56
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 55
The Italian Mitochondrial Registry: design and preliminary results 54
Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients 54
ANT1 is reduced in sporadic inclusion body myositis. 54
Clinical and electrophysiological characterization in a cohort of italian patients with different forms of hereditary spastic paraplegia 53
Muscle imaging findings in GNE myopathy. 52
A life threatening case of β-enolase deficiency 52
ANO10 mutations cause ataxia and coenzyme Q₁₀ deficiency 51
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 49
Auditory system involvement study in 20 patients with lateonset pompe disease 49
Wound botulism in drug users: a still underestimated diagnosis 48
Differential expression of microRNAs in primary and secondary calpainopathies 48
Metabolic Myoglobinuria 48
A MRI evaluation of respiratory function in patients with the late onset form of Pompe disease 47
CEREBELLAR ATAXIA AND SEVERE MUSCLE CoQ10 DEFICIENCY IN A PATIENT WITH A NOVEL MUTATION IN ADCK3 47
Late-onset Pompe disease (LOPD): Correlations between respiratory muscles CT and MRI features and pulmonary function 46
Deoxynucleoside stress exacerbates the phenotype of a mouse model of mitochondrial neurogastrointestinal encephalopathy 46
Clinical, morphological and genetic features of a large cohort of late onset GSDII patients: typical and atypical presentation 45
An unusual clinical presentation of Pompe disease charactherized by a severe distal myopathy 45
Un caso di rabdomiolisi massiva da deficit di β-enolasi 43
Facial onset sensory motor neuronopathy: not always a slowly progressive disorder. 42
Chapter 34 - Primary Cerebellar CoQ10 Deficiency 42
The clinical heterogeneity of coenzyme Q10 deficiency results from genotypic differences in the Coq9 gene 42
CoQ10 Deficiency Is Not a Common Finding in GLUT1 Deficiency Syndrome 40
Differential expression of microRNAs in primary and secondary calpainopathies 39
Coenzyme Q deficiency causes impairment of the sulfide oxidation pathway 35
Therapeutic approaches in the late onset form of GSD II 33
Deoxycytidine and Deoxythymidine Treatment for Thymidine Kinase 2 Deficiency 31
Coinvolgimento muscolare in un caso di sindrome di Sweet (dermatosi neutrofila febbrile) 30
Update on diagnostics of metabolic myopathies 30
Functional cellular analyses reveal energy metabolism defect and mitochondrial DNA depletion in a case of mitochondrial aconitase deficiency 29
Cytochrome c Oxidase Activity Is a Metabolic Checkpoint that Regulates Cell Fate Decisions During T Cell Activation and Differentiation 29
Muscle gene expression profile in adult onset patients with Pompe disease 28
Role of the autophagic process in adult-onset patients with Pompe disease 28
Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway 28
Decreased Coenzyme Q10 Levels in Multiple System Atrophy Cerebellum 28
Inhibition of NAPDH Oxidase 2 (NOX2) Prevents Oxidative Stress and Mitochondrial Abnormalities Caused by Saturated Fat in Cardiomyocytes 27
Role of the autophagic process in adult-onset patients with Pompe disease 26
Ruolo del processo autofagico nella forma ad insorgenza adulta di malattia di Pompe 23
Quantitative muscle MRI and functional measures in a cohort of late onset GSD II patients 23
New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy 23
Totale 2.329
Categoria #
all - tutte 10.526
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.526


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020200 0 0 0 0 4 64 19 9 8 47 37 12
2020/2021317 11 9 100 9 61 7 15 12 9 46 29 9
2021/2022395 3 40 4 25 19 4 35 18 8 67 56 116
2022/2023828 61 86 28 57 60 92 3 48 360 3 25 5
2023/2024206 22 26 21 19 17 37 1 14 1 20 3 25
2024/2025101 13 5 12 41 30 0 0 0 0 0 0 0
Totale 2.329